These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


588 related items for PubMed ID: 2528696

  • 1. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
    Joachim CL, Mori H, Selkoe DJ.
    Nature; 1989 Sep 21; 341(6239):226-30. PubMed ID: 2528696
    [Abstract] [Full Text] [Related]

  • 2. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S, Allsop D, Glenner GG.
    Prog Clin Biol Res; 1989 Sep 21; 317():313-23. PubMed ID: 2532370
    [Abstract] [Full Text] [Related]

  • 3. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.
    Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B.
    Nature; 1989 Sep 21; 325(6106):733-6. PubMed ID: 2881207
    [Abstract] [Full Text] [Related]

  • 4. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL.
    N Engl J Med; 1989 Jun 01; 320(22):1446-52. PubMed ID: 2566117
    [Abstract] [Full Text] [Related]

  • 5. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.
    Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL.
    Nature; 1988 Feb 11; 331(6156):528-30. PubMed ID: 2893290
    [Abstract] [Full Text] [Related]

  • 6. [Alzheimer's disease and Down's syndrome. Some recent etiopathogenic data].
    Golaz J, Charnay Y, Vallet P, Bouras C.
    Encephale; 1991 Feb 11; 17(1):29-31. PubMed ID: 1669030
    [Abstract] [Full Text] [Related]

  • 7. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ.
    Neurobiol Dis; 1996 Feb 11; 3(1):16-32. PubMed ID: 9173910
    [Abstract] [Full Text] [Related]

  • 8. [The pathogenesis of Alzheimer's disease demonstrated by immunocytochemistry with anti-beta-protein antibody].
    Ikeda S.
    Yakubutsu Seishin Kodo; 1992 Jun 11; 12(3):141-9. PubMed ID: 1414034
    [Abstract] [Full Text] [Related]

  • 9. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR, Potter H.
    Prog Clin Biol Res; 1989 Jun 11; 317():1037-48. PubMed ID: 2513582
    [Abstract] [Full Text] [Related]

  • 10. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene.
    Tanzi RE, St George-Hyslop PH, Haines JL, Polinsky RJ, Nee L, Foncin JF, Neve RL, McClatchey AI, Conneally PM, Gusella JF.
    Nature; 1989 Jun 11; 329(6135):156-7. PubMed ID: 2888020
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM.
    Acta Neuropathol; 2006 Aug 11; 112(2):163-74. PubMed ID: 16865398
    [Abstract] [Full Text] [Related]

  • 12. Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar?
    Davies CA, Mann DM.
    Am J Pathol; 1993 Dec 11; 143(6):1594-605. PubMed ID: 8256851
    [Abstract] [Full Text] [Related]

  • 13. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
    Tagliavini F, Giaccone G, Linoli G, Frangione B, Bugiani O.
    Prog Clin Biol Res; 1989 Dec 11; 317():1001-5. PubMed ID: 2532368
    [Abstract] [Full Text] [Related]

  • 14. Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families.
    Van Broeckhoven C, Genthe AM, Vandenberghe A, Horsthemke B, Backhovens H, Raeymaekers P, Van Hul W, Wehnert A, Gheuens J, Cras P.
    Nature; 1989 Dec 11; 329(6135):153-5. PubMed ID: 3306405
    [Abstract] [Full Text] [Related]

  • 15. Amyloid beta protein and the basis for Alzheimer's disease.
    Glenner GG.
    Prog Clin Biol Res; 1989 Dec 11; 317():857-68. PubMed ID: 2690126
    [Abstract] [Full Text] [Related]

  • 16. Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.
    Ikeda S, Yanagisawa N, Allsop D, Glenner GG.
    Lab Invest; 1989 Jul 11; 61(1):133-7. PubMed ID: 2473275
    [Abstract] [Full Text] [Related]

  • 17. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.
    Ikeda S, Allsop D, Glenner GG.
    Lab Invest; 1989 Jan 11; 60(1):113-22. PubMed ID: 2642985
    [Abstract] [Full Text] [Related]

  • 18. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C, Colle MA, Delatour B, Hauw JJ.
    Rev Neurol (Paris); 1999 Jan 11; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [Abstract] [Full Text] [Related]

  • 19. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN.
    Rev Neurosci; 1995 Jan 11; 6(4):287-316. PubMed ID: 8845971
    [Abstract] [Full Text] [Related]

  • 20. [Approach to the dementia research].
    Tomonaga M.
    Rinsho Shinkeigaku; 1989 Dec 11; 29(12):1532-5. PubMed ID: 2698299
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.